Mar 22 | Sep 21 | Mar 21 | Sep 20 | Mar 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 2.11B | $ 3.13B | $ 2.00B | $ 2.06B | $ 1.46B |
Total Assets | $ 6.68B | $ 7.70B | $ 7.31B | $ 7.10B | $ 8.31B |
Total Debt | $ 1.30B | $ 1.64B | $ 1.86B | $ 1.71B | $ 1.95B |
Net Debt | $ -810.49M | $ -1.49B | $ -136.79M | $ -343.99M | $ 487.31M |
Total Liabilities | $ 2.00B | $ 2.39B | $ 2.76B | $ 2.65B | $ 4.43B |
Stockholders Equity | $ 4.56B | $ 5.19B | $ 4.42B | $ 4.34B | $ 3.77B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |